Menopause: Clinical Trials

46 trials for Menopause, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed, 5 unknown, 4 recruiting, 2 terminated. 46 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 346Completed 32, Unknown 5, Recruiting 4, Terminated 2, Withdrawn 2, Active not recruiting 1
Phase 29Completed 5, Recruiting 3, Terminated 1

Follow Menopause: new trials by email Literature Review of Menopause trials Research Report on Menopause

Trials (filtered) newest first · largest first

All 46 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Metformin, semaglutide, Anti-hypertensives - Menopause, Menopause Hot Flashes
Phase 2 / Phase 3RecruitingUniversity of Colorado, Denver2002026-03-012026-11-03
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
testosterone pellet (100 mg), Placebo - Menopause, Testosterone Deficiency
Phase 3RecruitingUniversity of Sao Paulo General Hospital1402025-12-182025-12-29
Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women
0.20% sodium hyaluronate gel - Vaginismus, Vaginal Atrophy
Phase 3UnknownBiolab Sanus Farmaceutica452025-03-012024-08-21
The MUSE Study for Menopausal Arthralgia
Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause
Phase 2 / Phase 3RecruitingNational University Hospital, Singapore1002024-08-012024-07-31
Effect of Local Estriol Treatment Before Vaginal Repair Surgery
estriol cream - Pelvic Organ Prolapse, Pelvic Floor Disorders
Phase 3Active not recruitingHatice Tukenmez Kurnaz362024-04-012025-02-05
Testosterone Effects on Pelvic Floor Muscles
Testosterone Enanthate, Placebo - Urinary Incontinence, Menopause
Phase 3WithdrawnBrigham and Women's Hospital2021-01-012022-07-20
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
Prasterone, Placebo - Recurrent Urinary Tract Infection, Postmenopause
Phase 3WithdrawnOlivia Cardenas-Trowers, M.D.2020-05-012021-06-30
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Autologous PRP intra ovarian infusion, Autologous PFP intra ovarian infusion - Infertility, Female, Anovulatory Infertility
Phase 2 / Phase 3RecruitingGenesis Athens Clinic1002019-05-212026-07-08
Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
Intrarosa, Placebos - Menopause, Genitourinary Syndrome of Menopause
Phase 3UnknownCenter for Vulvovaginal Disorders402019-03-022019-01-31
The Vaginal Health Trial
Vagifem, Replens, Placebo tablet - Atrophy of Vagina, Menopause
Phase 3CompletedFred Hutchinson Cancer Center3022016-04-012018-07-12
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
oral estradiol 1.0 mg, oral progesterone 100 mg - Menopause
Phase 3CompletedIntira Sriprasert202015-12-012020-03-19
A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
proprietary formula - Menopause
Phase 2 / Phase 3TerminatedPhysician Recommended Nutriceuticals202015-03-012016-08-04
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
Estradiol, Placebo - Vulvovaginal Atrophy, Menopause
Phase 3CompletedTherapeuticsMD7642014-09-012017-05-25
Black Cohosh Extract for Treatment of Moderate to Severe Menopausal Symptoms
black cohosh extract, Placebo - Menopause, Quality of Life
Phase 3UnknownNavamindradhiraj University602014-03-012014-09-25
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
Estradiol, Progesterone, Placebo - Menopause
Phase 3CompletedTherapeuticsMD18452013-08-052019-05-06
Qing'E Formula Therapy on Menopausal Symptoms
Qing'E pills, Placebo - Menopause
Phase 2 / Phase 3CompletedShanghai University of Traditional Chinese Medicine2402013-03-012019-04-05
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
Topical liquid lidocaine, Topical saline - Vulvodynia, Dyspareunia
Phase 3CompletedOHSU Knight Cancer Institute502011-12-012017-04-14
Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)
Pegylated Interferon, Ribavirin, Boceprevir - Chronic Hepatitis C, Menopause
Phase 3UnknownUniversity of Modena and Reggio Emilia2402011-11-012012-10-02
Perimenopausal Estrogen Replacement Therapy Study
Estradiol, Placebo - Perimenopause, Menopause
Phase 2 / Phase 3CompletedUniversity of North Carolina, Chapel Hill1722010-10-012017-08-22
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Risedronate, Placebo - Breast Cancer, Menopause
Phase 3CompletedHospices Civils de Lyon202009-11-012013-10-31

Showing 20 of 46. Sign in to see all of them.

Narrower conditions

Hot Flashes (6)  ·  Dyspareunia (5)  ·  Osteoporosis (5)  ·  Bone Diseases, Metabolic (4)  ·  Breast Neoplasms (2)  ·  Amenorrhea (1)  ·  Arthralgia (1)  ·  Blushing (1)  ·  Cardiovascular Diseases (1)  ·  Depression (1)  ·  Diabetes Mellitus (1)  ·  Fever (1)  ·  Fractures, Bone (1)  ·  Heart Diseases (1)  ·  Hepatitis C, Chronic (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (13)  ·  Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Signs and Symptoms (10)  ·  Urogenital Diseases (10)  ·  Male Urogenital Diseases (8)  ·  Genital Diseases (7)  ·  Genital Diseases, Female (7)  ·  Mental Disorders (7)  ·  Musculoskeletal Diseases (7)  ·  Metabolic Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Sexual Dysfunction, Physiological (6)  ·  Sexual Dysfunctions, Psychological (6)  ·  Bone Diseases (5)

Interventions

Estradiol (12)  ·  Progesterone (4)  ·  Dehydroepiandrosterone (2)  ·  Estrogens, Conjugated (USP) (2)  ·  Medroxyprogesterone Acetate (2)  ·  Mirtazapine (2)  ·  black cohosh root extract (2)  ·  Angiotensin Receptor Antagonists (1)  ·  Antihypertensive Agents (1)  ·  Diet, Fat-Restricted (1)  ·  Estrogens (1)  ·  Exercise (1)  ·  Gabapentin (1)  ·  Genistein (1)  ·  Hormone Replacement Therapy (1)

Sponsors

Novo Nordisk A/S (6)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (3)  ·  Duramed Research (2)  ·  Merck Sharp & Dohme LLC (2)  ·  TherapeuticsMD (2)  ·  Bayer (1)  ·  Biolab Sanus Farmaceutica (1)  ·  Boehringer Ingelheim (1)  ·  Brigham and Women's Hospital (1)  ·  Center for Vulvovaginal Disorders (1)  ·  Centro A.F. de Estudios Tecnologicos, S.A. (1)  ·  Columbia University (1)  ·  Federal University of São Paulo (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Genesis Athens Clinic (1)

Countries

United States (17)  ·  Finland (5)  ·  Sweden (5)  ·  France (4)  ·  Belgium (3)  ·  Canada (3)  ·  Denmark (3)  ·  Hungary (3)  ·  Mexico (3)  ·  Norway (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  China (2)  ·  Czechia (2)  ·  Netherlands (2)

Top investigators

Adi Cohen, MD (1)  ·  Agni Pantou, MD (1)  ·  Andrea Z LaCroix, PhD (1)  ·  Caroline Mitchell, MD, MPH (1)  ·  David F Archer, MD (1)  ·  Debra Butt, MSc MD CCFP (1)  ·  Edmund Baracat, PhD (1)  ·  Elizabeth Shane, MD (1)

Results publications

PMID 18165394, PMID 18978105, PMID 20859151, PMID 30712391, PMID 17453860, PMID 17487652, PMID 17577003, PMID 1791769, PMID 18053998, PMID 18178111, PMID 18202966, PMID 19252451, PMID 20888118, PMID 21824950, PMID 23635731, PMID 24438370, PMID 24807329, PMID 25469044, PMID 25835751, PMID 26215946, PMID 27187320, PMID 28355090, PMID 29322164, PMID 29554173, PMID 29738424, PMID 29889748, PMID 30238814, PMID 30586005, PMID 30601452, PMID 30994576, PMID 31364889, PMID 31688572, PMID 31838497, PMID 31913228, PMID 32706883, PMID 32740481, PMID 32932401, PMID 33038141, PMID 33110039, PMID 33288437, PMID 33367735, PMID 33675793, PMID 34054104, PMID 35213517, PMID 35353163, PMID 36374501, PMID 37402281, PMID 37619252, PMID 38979716

NIH funding

2004 (2), 2023 (1), R01AR048932 (1), R01HL045167 (1), R01MH087619 (1)